中信证券:2026年医药行业有望维持超配

中证金牛座
Nov 13, 2025

中信证券发布研报称,展望2026年医药投资趋势,无论是国内医药企业在创新领域的集中兑现,还是政策端出台支持创新药械、优化集采、推动商保等一系列产业支持政策,医疗健康产业的内外因催化因素都有望延续。医疗健康产业开始逐步重新回归到临床价值和需求导向的市场价格定价体系,带来稳定且持续的国内医药市场环境和长坡厚雪的发展主基调,上市公司也有望迎来持续且稳定的业绩增长趋势,带来行业成长确定性的贝塔。医药行业...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10